How are arrhythmias managed in the paediatric population in Europe? Results of the European Heart Rhythm survey.
Identifieur interne : 001576 ( Ncbi/Merge ); précédent : 001575; suivant : 001577How are arrhythmias managed in the paediatric population in Europe? Results of the European Heart Rhythm survey.
Auteurs : Antonio Hernández-Madrid [Oman] ; Mélèze Hocini [France] ; Jian Chen [Norvège] ; Tatjana Potpara [Serbie] ; Laurent Pison [Pays-Bas] ; Carina Blomström-Lundqvist [Suède]Source :
- Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology [ 1532-2092 ] ; 2014.
English descriptors
- KwdEn :
- Adolescent, Anti-Arrhythmia Agents (therapeutic use), Arrhythmias, Cardiac (epidemiology), Arrhythmias, Cardiac (therapy), Atenolol (therapeutic use), Catheter Ablation (utilization), Child, Child, Preschool, Europe (epidemiology), Female, Flecainide (therapeutic use), Health Care Surveys, Humans, Infant, Infant, Newborn, Male, Pacemaker, Artificial (utilization), Practice Patterns, Physicians' (statistics & numerical data).
- MESH :
- chemical , therapeutic use : Anti-Arrhythmia Agents, Atenolol, Flecainide.
- geographic , epidemiology : Europe.
- epidemiology : Arrhythmias, Cardiac.
- statistics & numerical data : Practice Patterns, Physicians'.
- therapy : Arrhythmias, Cardiac.
- utilization : Catheter Ablation, Pacemaker, Artificial.
- Adolescent, Child, Child, Preschool, Female, Health Care Surveys, Humans, Infant, Infant, Newborn, Male.
Abstract
The aim of this survey was to provide insight into current practice regarding the management of paediatric arrhythmias in Europe. The survey was based on a questionnaire sent via the Internet to the European Heart Rhythm Association (EHRA) electrophysiology research network centres. The following topics were explored: patient and treatment selection, techniques and equipment, treatment outcomes and complications. The vast majority of paediatric arrhythmias concerns children older than 1 year and patients with grown-up congenital heart disease. In 65% of the hospitals there is a specialized paediatric centre, and the most commonly observed arrhythmias include Wolff-Parkinson-White syndrome and atrioventricular nodal re-entry tachycardias (90.24%). The medical staff performing paediatric catheter ablations in Europe are mainly adult electrophysiology teams (82.05% of the centres). Radiofrequency is the preferred energy source used for paediatric arrhythmia ablation. Catheter ablation is only chosen if two or more antiarrhythmic drugs have failed (94.59% of the centres). The majority of the centres use flecainide (37.8%) or atenolol (32.4%) as their first choice drug for prevention of recurrent supraventricular arrhythmias. While none of the centres performed catheter ablation in asymptomatic infants with pre-excitation, 29.7% recommend ablation in asymptomatic children and adolescents. The preferred choice for pacemaker leads in infants less than 1 year old is implantation of epicardial leads in 97.3% of the centres, which continues to be the routine even in patients between 1 and 5 years of age as reported by 75.68% of the hospitals. Almost all centres (94.59%) report equally small number of complications of catheter ablation in children (aged 1-14 years) as observed in adults.
DOI: 10.1093/europace/euu313
PubMed: 25417228
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000456
- to stream PubMed, to step Curation: 000447
- to stream PubMed, to step Checkpoint: 000447
Links to Exploration step
pubmed:25417228Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">How are arrhythmias managed in the paediatric population in Europe? Results of the European Heart Rhythm survey.</title><author><name sortKey="Hernandez Madrid, Antonio" sort="Hernandez Madrid, Antonio" uniqKey="Hernandez Madrid A" first="Antonio" last="Hernández-Madrid">Antonio Hernández-Madrid</name><affiliation wicri:level="1"><nlm:affiliation>Cardiology Department, Ramon y Cajal Hospital, Alcalá University, CarreteraColmenar Viejo 28034 Madrid, Spain antoniomadri@gmail.com.</nlm:affiliation><country wicri:rule="url">Oman</country><wicri:regionArea>Cardiology Department, Ramon y Cajal Hospital, Alcalá University, CarreteraColmenar Viejo 28034 Madrid</wicri:regionArea><wicri:noRegion>CarreteraColmenar Viejo 28034 Madrid</wicri:noRegion></affiliation></author><author><name sortKey="Hocini, Meleze" sort="Hocini, Meleze" uniqKey="Hocini M" first="Mélèze" last="Hocini">Mélèze Hocini</name><affiliation wicri:level="3"><nlm:affiliation>HôpitalCardiologique du Haut LévêqueUniversité Victor Segalen Bordeaux II, Bordeaux 33604 Pessac, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>HôpitalCardiologique du Haut LévêqueUniversité Victor Segalen Bordeaux II, Bordeaux 33604 Pessac</wicri:regionArea><placeName><region type="region" nuts="2">Nouvelle-Aquitaine</region><region type="old region" nuts="2">Aquitaine</region><settlement type="city">Pessac</settlement></placeName></affiliation></author><author><name sortKey="Chen, Jian" sort="Chen, Jian" uniqKey="Chen J" first="Jian" last="Chen">Jian Chen</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Medicine and Department of Heart Disease, Haukeland University Hospital, University of Bergen, N-5021 Bergen, Norway.</nlm:affiliation><country xml:lang="fr">Norvège</country><wicri:regionArea>Institute of Medicine and Department of Heart Disease, Haukeland University Hospital, University of Bergen, N-5021 Bergen</wicri:regionArea><wicri:noRegion>N-5021 Bergen</wicri:noRegion></affiliation></author><author><name sortKey="Potpara, Tatjana" sort="Potpara, Tatjana" uniqKey="Potpara T" first="Tatjana" last="Potpara">Tatjana Potpara</name><affiliation wicri:level="1"><nlm:affiliation>School of Medicine, Belgrade University, Cardiology Clinical centre Serbia, 11000 Belgrade, Serbia.</nlm:affiliation><country xml:lang="fr">Serbie</country><wicri:regionArea>School of Medicine, Belgrade University, Cardiology Clinical centre Serbia, 11000 Belgrade</wicri:regionArea><wicri:noRegion>11000 Belgrade</wicri:noRegion></affiliation></author><author><name sortKey="Pison, Laurent" sort="Pison, Laurent" uniqKey="Pison L" first="Laurent" last="Pison">Laurent Pison</name><affiliation wicri:level="1"><nlm:affiliation>Dept. of Cardiology, Maastricht University, Medical Centre, 6229 HX Maastricht, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Dept. of Cardiology, Maastricht University, Medical Centre, 6229 HX Maastricht</wicri:regionArea><wicri:noRegion>6229 HX Maastricht</wicri:noRegion></affiliation></author><author><name sortKey="Blomstrom Lundqvist, Carina" sort="Blomstrom Lundqvist, Carina" uniqKey="Blomstrom Lundqvist C" first="Carina" last="Blomström-Lundqvist">Carina Blomström-Lundqvist</name><affiliation wicri:level="4"><nlm:affiliation>Department of Cardiology, Institution of Medical Science, Uppsala University, 75185 Uppsala, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Cardiology, Institution of Medical Science, Uppsala University, 75185 Uppsala</wicri:regionArea><orgName type="university">Université d'Uppsala</orgName><placeName><settlement type="city">Uppsala</settlement><region nuts="1">Svealand</region><region nuts="1">East Middle Sweden</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:25417228</idno><idno type="pmid">25417228</idno><idno type="doi">10.1093/europace/euu313</idno><idno type="wicri:Area/PubMed/Corpus">000456</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000456</idno><idno type="wicri:Area/PubMed/Curation">000447</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000447</idno><idno type="wicri:Area/PubMed/Checkpoint">000447</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000447</idno><idno type="wicri:Area/Ncbi/Merge">001576</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">How are arrhythmias managed in the paediatric population in Europe? Results of the European Heart Rhythm survey.</title><author><name sortKey="Hernandez Madrid, Antonio" sort="Hernandez Madrid, Antonio" uniqKey="Hernandez Madrid A" first="Antonio" last="Hernández-Madrid">Antonio Hernández-Madrid</name><affiliation wicri:level="1"><nlm:affiliation>Cardiology Department, Ramon y Cajal Hospital, Alcalá University, CarreteraColmenar Viejo 28034 Madrid, Spain antoniomadri@gmail.com.</nlm:affiliation><country wicri:rule="url">Oman</country><wicri:regionArea>Cardiology Department, Ramon y Cajal Hospital, Alcalá University, CarreteraColmenar Viejo 28034 Madrid</wicri:regionArea><wicri:noRegion>CarreteraColmenar Viejo 28034 Madrid</wicri:noRegion></affiliation></author><author><name sortKey="Hocini, Meleze" sort="Hocini, Meleze" uniqKey="Hocini M" first="Mélèze" last="Hocini">Mélèze Hocini</name><affiliation wicri:level="3"><nlm:affiliation>HôpitalCardiologique du Haut LévêqueUniversité Victor Segalen Bordeaux II, Bordeaux 33604 Pessac, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>HôpitalCardiologique du Haut LévêqueUniversité Victor Segalen Bordeaux II, Bordeaux 33604 Pessac</wicri:regionArea><placeName><region type="region" nuts="2">Nouvelle-Aquitaine</region><region type="old region" nuts="2">Aquitaine</region><settlement type="city">Pessac</settlement></placeName></affiliation></author><author><name sortKey="Chen, Jian" sort="Chen, Jian" uniqKey="Chen J" first="Jian" last="Chen">Jian Chen</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Medicine and Department of Heart Disease, Haukeland University Hospital, University of Bergen, N-5021 Bergen, Norway.</nlm:affiliation><country xml:lang="fr">Norvège</country><wicri:regionArea>Institute of Medicine and Department of Heart Disease, Haukeland University Hospital, University of Bergen, N-5021 Bergen</wicri:regionArea><wicri:noRegion>N-5021 Bergen</wicri:noRegion></affiliation></author><author><name sortKey="Potpara, Tatjana" sort="Potpara, Tatjana" uniqKey="Potpara T" first="Tatjana" last="Potpara">Tatjana Potpara</name><affiliation wicri:level="1"><nlm:affiliation>School of Medicine, Belgrade University, Cardiology Clinical centre Serbia, 11000 Belgrade, Serbia.</nlm:affiliation><country xml:lang="fr">Serbie</country><wicri:regionArea>School of Medicine, Belgrade University, Cardiology Clinical centre Serbia, 11000 Belgrade</wicri:regionArea><wicri:noRegion>11000 Belgrade</wicri:noRegion></affiliation></author><author><name sortKey="Pison, Laurent" sort="Pison, Laurent" uniqKey="Pison L" first="Laurent" last="Pison">Laurent Pison</name><affiliation wicri:level="1"><nlm:affiliation>Dept. of Cardiology, Maastricht University, Medical Centre, 6229 HX Maastricht, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Dept. of Cardiology, Maastricht University, Medical Centre, 6229 HX Maastricht</wicri:regionArea><wicri:noRegion>6229 HX Maastricht</wicri:noRegion></affiliation></author><author><name sortKey="Blomstrom Lundqvist, Carina" sort="Blomstrom Lundqvist, Carina" uniqKey="Blomstrom Lundqvist C" first="Carina" last="Blomström-Lundqvist">Carina Blomström-Lundqvist</name><affiliation wicri:level="4"><nlm:affiliation>Department of Cardiology, Institution of Medical Science, Uppsala University, 75185 Uppsala, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Cardiology, Institution of Medical Science, Uppsala University, 75185 Uppsala</wicri:regionArea><orgName type="university">Université d'Uppsala</orgName><placeName><settlement type="city">Uppsala</settlement><region nuts="1">Svealand</region><region nuts="1">East Middle Sweden</region></placeName></affiliation></author></analytic><series><title level="j">Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology</title><idno type="eISSN">1532-2092</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Anti-Arrhythmia Agents (therapeutic use)</term><term>Arrhythmias, Cardiac (epidemiology)</term><term>Arrhythmias, Cardiac (therapy)</term><term>Atenolol (therapeutic use)</term><term>Catheter Ablation (utilization)</term><term>Child</term><term>Child, Preschool</term><term>Europe (epidemiology)</term><term>Female</term><term>Flecainide (therapeutic use)</term><term>Health Care Surveys</term><term>Humans</term><term>Infant</term><term>Infant, Newborn</term><term>Male</term><term>Pacemaker, Artificial (utilization)</term><term>Practice Patterns, Physicians' (statistics & numerical data)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Arrhythmia Agents</term><term>Atenolol</term><term>Flecainide</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Europe</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Arrhythmias, Cardiac</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Practice Patterns, Physicians'</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Arrhythmias, Cardiac</term></keywords><keywords scheme="MESH" qualifier="utilization" xml:lang="en"><term>Catheter Ablation</term><term>Pacemaker, Artificial</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Child</term><term>Child, Preschool</term><term>Female</term><term>Health Care Surveys</term><term>Humans</term><term>Infant</term><term>Infant, Newborn</term><term>Male</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The aim of this survey was to provide insight into current practice regarding the management of paediatric arrhythmias in Europe. The survey was based on a questionnaire sent via the Internet to the European Heart Rhythm Association (EHRA) electrophysiology research network centres. The following topics were explored: patient and treatment selection, techniques and equipment, treatment outcomes and complications. The vast majority of paediatric arrhythmias concerns children older than 1 year and patients with grown-up congenital heart disease. In 65% of the hospitals there is a specialized paediatric centre, and the most commonly observed arrhythmias include Wolff-Parkinson-White syndrome and atrioventricular nodal re-entry tachycardias (90.24%). The medical staff performing paediatric catheter ablations in Europe are mainly adult electrophysiology teams (82.05% of the centres). Radiofrequency is the preferred energy source used for paediatric arrhythmia ablation. Catheter ablation is only chosen if two or more antiarrhythmic drugs have failed (94.59% of the centres). The majority of the centres use flecainide (37.8%) or atenolol (32.4%) as their first choice drug for prevention of recurrent supraventricular arrhythmias. While none of the centres performed catheter ablation in asymptomatic infants with pre-excitation, 29.7% recommend ablation in asymptomatic children and adolescents. The preferred choice for pacemaker leads in infants less than 1 year old is implantation of epicardial leads in 97.3% of the centres, which continues to be the routine even in patients between 1 and 5 years of age as reported by 75.68% of the hospitals. Almost all centres (94.59%) report equally small number of complications of catheter ablation in children (aged 1-14 years) as observed in adults.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25417228</PMID><DateCreated><Year>2014</Year><Month>11</Month><Day>24</Day></DateCreated><DateCompleted><Year>2015</Year><Month>07</Month><Day>23</Day></DateCompleted><DateRevised><Year>2016</Year><Month>04</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1532-2092</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>12</Issue><PubDate><Year>2014</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology</Title><ISOAbbreviation>Europace</ISOAbbreviation></Journal><ArticleTitle>How are arrhythmias managed in the paediatric population in Europe? Results of the European Heart Rhythm survey.</ArticleTitle><Pagination><MedlinePgn>1852-6</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/europace/euu313</ELocationID><Abstract><AbstractText>The aim of this survey was to provide insight into current practice regarding the management of paediatric arrhythmias in Europe. The survey was based on a questionnaire sent via the Internet to the European Heart Rhythm Association (EHRA) electrophysiology research network centres. The following topics were explored: patient and treatment selection, techniques and equipment, treatment outcomes and complications. The vast majority of paediatric arrhythmias concerns children older than 1 year and patients with grown-up congenital heart disease. In 65% of the hospitals there is a specialized paediatric centre, and the most commonly observed arrhythmias include Wolff-Parkinson-White syndrome and atrioventricular nodal re-entry tachycardias (90.24%). The medical staff performing paediatric catheter ablations in Europe are mainly adult electrophysiology teams (82.05% of the centres). Radiofrequency is the preferred energy source used for paediatric arrhythmia ablation. Catheter ablation is only chosen if two or more antiarrhythmic drugs have failed (94.59% of the centres). The majority of the centres use flecainide (37.8%) or atenolol (32.4%) as their first choice drug for prevention of recurrent supraventricular arrhythmias. While none of the centres performed catheter ablation in asymptomatic infants with pre-excitation, 29.7% recommend ablation in asymptomatic children and adolescents. The preferred choice for pacemaker leads in infants less than 1 year old is implantation of epicardial leads in 97.3% of the centres, which continues to be the routine even in patients between 1 and 5 years of age as reported by 75.68% of the hospitals. Almost all centres (94.59%) report equally small number of complications of catheter ablation in children (aged 1-14 years) as observed in adults.</AbstractText><CopyrightInformation>Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2014. For permissions please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hernández-Madrid</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiology Department, Ramon y Cajal Hospital, Alcalá University, CarreteraColmenar Viejo 28034 Madrid, Spain antoniomadri@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hocini</LastName><ForeName>Mélèze</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>HôpitalCardiologique du Haut LévêqueUniversité Victor Segalen Bordeaux II, Bordeaux 33604 Pessac, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Medicine and Department of Heart Disease, Haukeland University Hospital, University of Bergen, N-5021 Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Potpara</LastName><ForeName>Tatjana</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>School of Medicine, Belgrade University, Cardiology Clinical centre Serbia, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pison</LastName><ForeName>Laurent</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Dept. of Cardiology, Maastricht University, Medical Centre, 6229 HX Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blomström-Lundqvist</LastName><ForeName>Carina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Institution of Medical Science, Uppsala University, 75185 Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Scientific Initiative Committee, European Heart Rhythm Association</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Europace</MedlineTA><NlmUniqueID>100883649</NlmUniqueID><ISSNLinking>1099-5129</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000889">Anti-Arrhythmia Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>50VV3VW0TI</RegistryNumber><NameOfSubstance UI="D001262">Atenolol</NameOfSubstance></Chemical><Chemical><RegistryNumber>K94FTS1806</RegistryNumber><NameOfSubstance UI="D005424">Flecainide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Europace. 2015 Dec;17(12):1879-80</RefSource><PMID Version="1">25995396</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Europace. 2015 Dec;17(12):1879</RefSource><PMID Version="1">25995398</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000889" MajorTopicYN="N">Anti-Arrhythmia Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="N">Arrhythmias, Cardiac</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001262" MajorTopicYN="N">Atenolol</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="N">Catheter Ablation</DescriptorName><QualifierName UI="Q000656" MajorTopicYN="Y">utilization</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005424" MajorTopicYN="N">Flecainide</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019538" MajorTopicYN="N">Health Care Surveys</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010138" MajorTopicYN="N">Pacemaker, Artificial</DescriptorName><QualifierName UI="Q000656" MajorTopicYN="Y">utilization</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010818" MajorTopicYN="N">Practice Patterns, Physicians'</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ablation</Keyword><Keyword MajorTopicYN="N">Arrhythmia</Keyword><Keyword MajorTopicYN="N">Children</Keyword><Keyword MajorTopicYN="N">Congenital heart disease</Keyword><Keyword MajorTopicYN="N">EHRA survey</Keyword><Keyword MajorTopicYN="N">EP wire</Keyword><Keyword MajorTopicYN="N">Pacing</Keyword><Keyword MajorTopicYN="N">Paediatric</Keyword><Keyword MajorTopicYN="N">Supraventricular tachycardia</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Blomström-Lundqvist</LastName><ForeName>Carina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bongiorni</LastName><ForeName>Maria Grazia</ForeName><Initials>MG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chen</LastName><ForeName>Jian</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dagres</LastName><ForeName>Nikolaos</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Estner</LastName><ForeName>Heidi</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hernandez-Madrid</LastName><ForeName>Antonio</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hocini</LastName><ForeName>Melece</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Larsen</LastName><ForeName>Torben Bjerregaard</ForeName><Initials>TB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pison</LastName><ForeName>Laurent</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Potpara</LastName><ForeName>Tatjana</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Proclemer</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sciraffia</LastName><ForeName>Elena</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Todd</LastName><ForeName>Derick</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Savelieva</LastName><ForeName>Irene</ForeName><Initials>I</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>11</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>11</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25417228</ArticleId><ArticleId IdType="pii">euu313</ArticleId><ArticleId IdType="doi">10.1093/europace/euu313</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>France</li><li>Norvège</li><li>Oman</li><li>Pays-Bas</li><li>Serbie</li><li>Suède</li></country><region><li>Aquitaine</li><li>East Middle Sweden</li><li>Nouvelle-Aquitaine</li><li>Svealand</li></region><settlement><li>Pessac</li><li>Uppsala</li></settlement><orgName><li>Université d'Uppsala</li></orgName></list><tree><country name="Oman"><noRegion><name sortKey="Hernandez Madrid, Antonio" sort="Hernandez Madrid, Antonio" uniqKey="Hernandez Madrid A" first="Antonio" last="Hernández-Madrid">Antonio Hernández-Madrid</name></noRegion></country><country name="France"><region name="Nouvelle-Aquitaine"><name sortKey="Hocini, Meleze" sort="Hocini, Meleze" uniqKey="Hocini M" first="Mélèze" last="Hocini">Mélèze Hocini</name></region></country><country name="Norvège"><noRegion><name sortKey="Chen, Jian" sort="Chen, Jian" uniqKey="Chen J" first="Jian" last="Chen">Jian Chen</name></noRegion></country><country name="Serbie"><noRegion><name sortKey="Potpara, Tatjana" sort="Potpara, Tatjana" uniqKey="Potpara T" first="Tatjana" last="Potpara">Tatjana Potpara</name></noRegion></country><country name="Pays-Bas"><noRegion><name sortKey="Pison, Laurent" sort="Pison, Laurent" uniqKey="Pison L" first="Laurent" last="Pison">Laurent Pison</name></noRegion></country><country name="Suède"><region name="Svealand"><name sortKey="Blomstrom Lundqvist, Carina" sort="Blomstrom Lundqvist, Carina" uniqKey="Blomstrom Lundqvist C" first="Carina" last="Blomström-Lundqvist">Carina Blomström-Lundqvist</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001576 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 001576 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:25417228
|texte= How are arrhythmias managed in the paediatric population in Europe? Results of the European Heart Rhythm survey.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:25417228" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonFranceV1
| This area was generated with Dilib version V0.6.29. |  |